Bill
Bill > HR383
US HR383
US HR383To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.
summary
Introduced
01/17/2023
01/17/2023
In Committee
01/27/2023
01/27/2023
Crossed Over
Passed
Dead
01/03/2025
01/03/2025
Introduced Session
118th Congress
Bill Summary
A BILL To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.
AI Summary
This bill aims to nullify the modifications made by the Food and Drug Administration (FDA) in January 2023 to the risk evaluation and mitigation strategy (REMS) for the abortion pill mifepristone. The bill prohibits the Secretary of Health and Human Services from establishing, implementing, or enforcing any provision of a REMS for mifepristone that is substantially similar to the nullified modifications.
Committee Categories
Business and Industry, Health and Social Services
Sponsors (27)
Diana Harshbarger (R)*,
Robert Aderholt (R),
Jim Baird (R),
Jim Banks (R),
Lauren Boebert (R),
Mike Bost (R),
Buddy Carter (R),
Jeff Duncan (R),
Randy Feenstra (R),
Mike Flood (R),
Tony Gonzales (R),
Paul Gosar (R),
Glenn Grothman (R),
Michael Guest (R),
Kevin Hern (R),
Clay Higgins (R),
Ronny Jackson (R),
Doug Lamborn (R),
Anna Luna (R),
Brian Mast (R),
Mary Miller (R),
John Moolenaar (R),
Pete Sessions (R),
Chris Smith (R),
Randy Weber (R),
Daniel Webster (R),
Rudy Yakym (R),
Last Action
Referred to the Subcommittee on Health. (on 01/27/2023)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.congress.gov/bill/118th-congress/house-bill/383/all-info |
| BillText | https://www.congress.gov/118/bills/hr383/BILLS-118hr383ih.pdf |
Loading...